Apixaban plasma levels in patients with HeartMate3 on JHLT: The Podcast
Published 10 April 2025
First author Charlotte Van Edom of the University Hospitals Leuven in Belgium is the guest on the latest episode of JHLT: The Podcast. She's joined to discuss her paper, "Apixaban plasma levels in patients with HeartMate 3 support."
You can also stream the podcast on Spotify, Amazon, iTunes, and anywhere else you get podcasts.
In the episode, you'll hear about:
- The evolution of the use and understanding of direct oral anticoagulants (DOACs) during LVAD support, including the increased focus on Factor Xa inhibitors
- Encouraging findings from the study and what clinical practices might need to change if introducing apixaban
- Additional studies exploring DOACs in LVAD patients
For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you’re an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.
Don’t already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.